Olanzapine and aspartate aminotransferase increased Patient Reports February 12, 2012

Olanzapine Side Effects Report #5352843-8
Olanzapine side effect was reported by a Physician from SPAIN on June 01, 2007. Female patient, 58 years of age, was diagnosed with schizophrenia, paranoid type and was treated with Olanzapine. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased, blood creatine phosphokinase increased, blood glucose increased, electrocardiogram qt prolonged, intentional overdose, leukocytosis, loss of consciousness, metabolic acidosis. Olanzapine dosage: unknown. Patient was hospitalized. Patient recovered.

Olanzapine Side Effects Report #5102953-5
Olanzapine side effect was reported by a Physician from JAPAN on Aug 17, 2006. Female patient, 47 years of age, weighting 193.1 lb, was diagnosed with schizophrenia, disorganised type and was treated with Olanzapine. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased, feeling abnormal, loss of consciousness. Olanzapine dosage: 10 MG, DAILY (1/D), ORAL. During the same period patient was treated with HIBERNA, ARTANE, AKINETON, RIVOTRIL, ISONIAZID, RISPERDAL, PANTOSIN, MAGNESIUM OXIDE. Patient recovered.

Olanzapine Side Effects Report #4953917-3
Olanzapine side effect was reported by a Pharmacist from CANADA on Mar 07, 2006. Male patient, 59 years of age, weighting 130.1 lb, was diagnosed with schizophrenia and was treated with Olanzapine. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, anion gap increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood amylase increased, blood bilirubin increased, blood lactate dehydrogenase increased, blood pressure increased, dysarthria. Olanzapine dosage: unknown. During the same period patient was treated with IRON, ASCORBIC ACID. Patient was hospitalized. Patient recovered.

Olanzapine Side Effects Report #5022606-1
Olanzapine side effect was reported by a Pharmacist from CANADA on May 17, 2006. Male patient, 59 years of age, weighting 130.1 lb, was diagnosed with schizophrenia and was treated with Olanzapine. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, haemodialysis, neuroleptic malignant syndrome, pneumonia , renal failure acute. Olanzapine dosage: 10 MG, EACH EVENING, ORAL. During the same period patient was treated with IRON, ASCORBIC ACID. Patient was hospitalized. Patient recovered.


Olanzapine Side Effects Report #4686665-8
Olanzapine side effect was reported by a Consumer or non-health professional from on May 18, 2005. Female patient, 49 years of age, was diagnosed with schizophrenia and was treated with Olanzapine. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, cerebrovascular accident, glycosuria, hyponatraemia, polydipsia. Olanzapine dosage: 20 MG DAY. During the same period patient was treated with TRAZODONE, PAXIL, RISPERIDONE. Patient was hospitalized. Patient recovered.

Olanzapine Side Effects Report #4759224-6
Olanzapine side effect was reported by a Physician from SWITZERLAND on May 26, 2004. Female patient, 47 years of age, was diagnosed with schizophrenia and was treated with Olanzapine. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, gamma-glutamyltransferase increased, muscle spasticity, urinary tract infection , vomiting. Olanzapine dosage: 7.5 MG DAY. During the same period patient was treated with GUTRON, CLOZAPINE, REMERON. Patient recovered.

Olanzapine Side Effects Report #4808718-3
Olanzapine side effect was reported by a Physician from ITALY on Sept 16, 2003. Male patient, 40 years of age, was diagnosed with schizophrenia and was treated with Olanzapine. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood glucose increased, eosinophilia. Olanzapine dosage: 10 MG/DAY. Patient recovered.

Olanzapine Side Effects Report #4870677-5
Olanzapine side effect was reported by a Pharmacist from NETHERLANDS on Dec 02, 2005. Male patient, 39 years of age, was diagnosed with schizophrenia and was treated with Olanzapine. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood creatine phosphokinase increased, blood lactate dehydrogenase increased, myalgia. Olanzapine dosage: unknown. During the same period patient was treated with PANTOPRAZOLE, PROMETHAZINE, OXAZEPAM. Patient was hospitalized. Patient recovered.

Olanzapine Side Effects Report #5243936-4
Olanzapine side effect was reported by a Consumer or non-health professional from UNITED STATES on Feb 12, 2007. Male patient, 37 years of age, weighting 265.0 lb, was diagnosed with schizophrenia and was treated with Olanzapine. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, diabetes mellitus non-insulin-dependent, haematocrit decreased, haemoglobin decreased, hypertension, red blood cell count decreased, weight increased. Olanzapine dosage: unknown. During the same period patient was treated with CYCLOBENZAPRINE, QUETIAPINE FUMARATE, TOPIRAMATE, GABAPENTIN, ESCITALOPRAM OXALATE, BUPROPION, TIZANIDINE. Patient recovered.


Olanzapine Side Effects Report #5646358-7
Olanzapine side effect was reported by a Physician from CZECH REPUBLIC on Feb 25, 2008. Male patient, 28 years of age, was diagnosed with schizophrenia, extrapyramidal disorder and was treated with Olanzapine. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood creatine phosphokinase increased, blood creatinine increased, blood urea increased, brain oedema, cardiac arrest , condition aggravated, cyanosis. Olanzapine dosage: 30 MG, DAILY (1/D). During the same period patient was treated with SEROQUEL, ZOLOFT, AKINETON. Patient was hospitalized. Patient died on 07/08/2007.

Olanzapine Side Effects Report #4915789-2
Olanzapine side effect was reported by a Physician from UNITED STATES on Jan 25, 2006. Male patient, 27 years of age, weighting 141.1 lb, was diagnosed with schizophrenia and was treated with Olanzapine. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood calcium increased, blood lactate dehydrogenase increased, eosinophil count increased, high density lipoprotein decreased, hypercholesterolaemia, low density lipoprotein increased, protein total increased. Olanzapine dosage: 15 MG, DAILY (1/D), ORAL. Patient recovered.

Olanzapine Side Effects Report #4614050-3
Olanzapine side effect was reported by a Consumer or non-health professional from on Mar 01, 2005. Male patient, 26 years of age, weighting 141.1 lb, was diagnosed with schizophrenia and was treated with Olanzapine. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood cholesterol increased, blood lactate dehydrogenase increased, eosinophil count increased. Olanzapine dosage: unknown. Patient recovered.

Olanzapine Side Effects Report #4844642-8
Olanzapine side effect was reported by a Physician from GERMANY on Nov 14, 2005. Male patient, 33 years of age, was diagnosed with schizoaffective disorder and was treated with Olanzapine. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood creatine phosphokinase mm increased, myoglobin blood increased. Olanzapine dosage: unknown. During the same period patient was treated with AMITRIPTYLINOXIDE. Patient recovered.

Olanzapine Side Effects Report #4563807-6
Olanzapine side effect was reported by a Physician from on Dec 16, 2004. Female patient, 38 years of age, was diagnosed with mental disorder and was treated with Olanzapine. After drug was administered, patient experienced the following side effects: abortion spontaneous, alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood cholesterol increased, bronchitis , condition aggravated, diabetes mellitus, difficulty in walking. Olanzapine dosage: 20 MG. During the same period patient was treated with PROZAC, LORAZEPAM, METFORMIN, GLYBURIDE, PREVACID, AMOXICILLIN AND CLAVULANATE POTASSIUM, LEVORA. Patient recovered.


Olanzapine Side Effects Report #4785114-9
Olanzapine side effect was reported by a Physician from TAIWAN, PROVINCE OF CHINA on Sept 12, 2005. Female patient, 44 years of age, weighting 94.80 lb, was diagnosed with mania and was treated with Olanzapine. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, bipolar i disorder, blood sodium decreased, haemoglobin decreased, neutrophil percentage increased. Olanzapine dosage: 10 MG/1 DAY. During the same period patient was treated with DEPAKENE. Patient was hospitalized. Patient recovered.

Olanzapine Side Effects Report #4788911-9
Olanzapine side effect was reported by a Physician from TAIWAN, PROVINCE OF CHINA on Sept 21, 2005. Female patient, 44 years of age, weighting 94.80 lb, was diagnosed with mania and was treated with Olanzapine. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, bipolar i disorder, blood sodium decreased, euphoric mood, haemoglobin decreased, mania, neutrophil percentage increased. Olanzapine dosage: 10 MG/1 DAY. During the same period patient was treated with DEPAKINE. Patient was hospitalized. Patient recovered.

Olanzapine Side Effects Report #4800526-2
Olanzapine side effect was reported by a Health Professional from TAIWAN, PROVINCE OF CHINA on Sept 26, 2005. Female patient, 44 years of age, weighting 94.80 lb, was diagnosed with mania and was treated with Olanzapine. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, anaemia, aspartate aminotransferase increased, bipolar i disorder, communication disorder, delusion, distractibility, elevated mood, irritability. Olanzapine dosage: 10 MG/1 DAY. During the same period patient was treated with DEPAKENE. Patient was hospitalized. Patient recovered.

Olanzapine Side Effects Report #5571512-2
Olanzapine side effect was reported by a Physician from GERMANY on Dec 17, 2007. Male patient, 55 years of age, was diagnosed with depression  and was treated with Olanzapine. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood cholesterol increased, blood triglycerides increased, white blood cell count increased. Olanzapine dosage: 15 MG, EACH EVENING. During the same period patient was treated with MIRTAZAPINE. Patient recovered.

Olanzapine Side Effects Report #4907062-3
Olanzapine side effect was reported by a Consumer or non-health professional from UNITED STATES on Jan 16, 2006. Female patient, 48 years of age, weighting 149.9 lb, was diagnosed with depression  and was treated with Olanzapine. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood cholesterol increased, blood glucose increased, blood triglycerides increased, cardiovascular disorder, cystitis, dehydration, diabetes mellitus. Olanzapine dosage: unknown. During the same period patient was treated with REMERON, NEURONTIN, PAXIL, PREVACID, TRICOR, VIOXX. Patient was hospitalized. Patient recovered.


Olanzapine Side Effects Report #5630221-1
Olanzapine side effect was reported by a Physician from GERMANY on Feb 08, 2008. Female patient, 41 years of age, was diagnosed with depression  and was treated with Olanzapine. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, hepatic enzyme increased. Olanzapine dosage: 5 MG, UNK. During the same period patient was treated with TAVOR, CIPRALEX. Patient was hospitalized. Patient recovered.

Olanzapine Side Effects Report #5630217-X
Olanzapine side effect was reported by a Physician from GERMANY on Feb 08, 2008. Female patient, weighting 138.9 lb, was diagnosed with depression  and was treated with Olanzapine. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood creatine phosphokinase increased, c-reactive protein increased, depressive delusion, hypothermia , inappropriate antidiuretic hormone secretion, neuroleptic malignant syndrome. Olanzapine dosage: 15 MG, EACH EVENING. During the same period patient was treated with SEROQUEL, DOMINAL, ESTRADIOL VALERATE, EUTHYROX, TAVOR, JATROSOM. Patient was hospitalized. Patient recovered.

Olanzapine Side Effects Report #4909419-3
Olanzapine side effect was reported by a Pharmacist from UNITED STATES on Feb 10, 2006. Male patient, weighting 132.3 lb, was diagnosed with dementia , depression  and was treated with Olanzapine. After drug was administered, patient experienced the following side effects: abdominal pain , alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, hepatic function abnormal, nausea . Olanzapine dosage: 10MG BID PO. During the same period patient was treated with CITALOPRAM. Patient was hospitalized. Patient recovered.

Olanzapine Side Effects Report #4765786-5
Olanzapine side effect was reported by a Consumer or non-health professional from SPAIN on Aug 18, 2005. Male patient, 58 years of age, weighting 220.5 lb, was diagnosed with bipolar disorder  and was treated with Olanzapine. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased, blood creatine phosphokinase increased, blood lactate dehydrogenase increased, csf protein increased, demyelination, gamma-glutamyltransferase increased, hypersensitivity, neuropathy peripheral, rash . Olanzapine dosage: 5 MG DAY. During the same period patient was treated with CLONAZEPAM, VALPROIC ACID, PREDNISONE, FLUNITRAZEPAM. Patient was hospitalized. Patient recovered.

Olanzapine Side Effects Report #4767646-2
Olanzapine side effect was reported by a Consumer or non-health professional from SPAIN on Sept 02, 2005. Male patient, 58 years of age, weighting 220.5 lb, was diagnosed with bipolar disorder  and was treated with Olanzapine. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased, blood creatine phosphokinase increased, blood lactate dehydrogenase increased, demyelinating polyneuropathy, gamma-glutamyltransferase increased, hypersensitivity. Olanzapine dosage: 5 MG DAY. During the same period patient was treated with CLONAZEPAM, VALPROIC ACID, PREDNISONE, FLUNITRAZEPAM. Patient was hospitalized. Patient recovered.


Olanzapine Side Effects Report #4872700-0
Olanzapine side effect was reported by a Consumer or non-health professional from UNITED STATES on Dec 21, 2005. Male patient, 38 years of age, weighting 312.8 lb, was diagnosed with bipolar disorder  and was treated with Olanzapine. After drug was administered, patient experienced the following side effects: agitation, alanine aminotransferase increased, aspartate aminotransferase increased, delirium, diabetes mellitus non-insulin-dependent, electrocardiogram t wave inversion, fall , hypertension, infection . Olanzapine dosage: 2.5 MG, AS NEEDED. During the same period patient was treated with ZESTRIL. Patient was hospitalized. Patient recovered.

Olanzapine Side Effects Report #5525142-9
Olanzapine side effect was reported by a Physician from GERMANY on Nov 12, 2007. Female patient, 64 years of age, was treated with Olanzapine. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, gamma-glutamyltransferase increased. Olanzapine dosage: 10 MG, UNK. During the same period patient was treated with LITHIUM CARBONATE, LITHIUM CARBONATE, CIPRALEX, ACETYLSALICYLSAEURE, TRUXAL, PANTOPRAZOLE, VOLTAREN. Patient recovered.

Olanzapine Side Effects Report #5502696-X
Olanzapine side effect was reported by a Physician from GERMANY on Oct 26, 2007. Male patient, 55 years of age, was treated with Olanzapine. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, white blood cell count increased. Olanzapine dosage: 15 MG, EACH EVENING. During the same period patient was treated with MIRTAZAPINE. Patient recovered.

Olanzapine Side Effects Report #5156068-0
Olanzapine side effect was reported by a Physician from AUSTRALIA on Oct 24, 2006. Male patient, 25 years of age, was diagnosed with schizophrenia and was treated with Olanzapine. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, gamma-glutamyltransferase increased, hepatic function abnormal. Olanzapine dosage: 30 MG DAILY AT NIGHTIME. During the same period patient was treated with CLOZARIL. Patient recovered.